-- Huadong Medicine's (SHE:000963) attributable profit rose 9.6% to 1.00 billion yuan in the first quarter from 914.7 million yuan in the year-ago period, according to a Friday filing with the Shenzhen bourse.
Earnings per share at the drug maker increased to 0.5715 yuan from 0.5213 yuan in the prior-year period.
Operating income grew 4.2% year over year to 11.2 billion yuan from 10.7 billion yuan.
Shares increased 3% during afternoon trading on Friday.
China's installed power generation capacity rose 15.5% year over year to 3.96 billion kilowatts at the end of March, according to the National Energy Administration.Solar power went up 31.3% to 1.24 billion kW, while wind power climbed 22.4% to 660 million kW.Utilization hours declined 66 hours to 703 in the first quarter.
Sun Pharmaceutical Industries (NSE:SUNPHARMA, BOM:524715) has incorporated a new wholly-owned subsidiary company in the US named "Sun Pharma America, Inc." according to a Friday filing to the Indian stock exchanges.The new subsidiary has been formed as part of the company's internal group structuring.The company's shares were down nearly 4% n recent trade.
Keyence's (TYO:6861) net income attributable to owners of the parent climbed 12% to 445.2 billion yen for the fiscal year ended March 20 from 398.7 billion yen a year earlier.The factory automation equipment maker's basic earnings per share increased to 1,835.63 yen from 1,643.77 yen a year ago, according to a Tokyo bourse filing on Friday.Net sales jumped 10% to 1.169 trillion yen from 1.059 trillion yen in the prior year.Keyence plans to pay interim and year-end dividends of 275 yen per share, each, for the current fiscal year, which is higher than the amount paid in the year-ago period.